Tel. +335 47 74 69 00 contacts: [email protected][email protected]RESCOLL AQUITAINE 8 allée Geoffroy Saint Hilaire 33600 Pessac RESCOLL RHONE ALPES 43 boulevard du 11novembre 1918 69100 Villeurbanne ISO 9001 ISO 13485 Impossible d’afficher l’image. RESCOLL Leading to competitiveness through innovation in polymers, composites, surface treatments, bonding technology and processes www.rescoll-medical.com
19
Embed
RESCOLL - bnn.at · RESCOLL can help you with your chemical and physiochemical analysis, stability validation and mechanical characterization thanks to our COFRAC ISO 17025 and ISO
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
RESCOLL is a service company specialized in the characterization and development of biomaterials (polymers,composites & metals) and medical devices. Over 20 years of scientific and technical experience give us theexpertise to support the development of your medical devices and biomaterials.
RESCOLL can help you with your chemical and physiochemical analysis, stability validation and mechanicalcharacterization thanks to our COFRAC ISO 17025 and ISO 9001 accredited laboratories.
RESCOLL Manufacturing allows us to offer a wide range of services to control and manufacture your medicaldevices and instruments. All control and manufacturing stages are conducted in an ISO 13485 certifiedenvironment.
The combined expertise of RESCOLL and RESCOLL Manufacturing allows us to propose a unique offering in France and in Europe. To offer a wide range of tools to help you develop your innovative projects and reach
your market as quickly and safely as possible.
Medical activities
MANUFACTURINGTESTING DEVELOPMENT
Training
ISO 9001 – ISO 17025 COFRAC ISO 9001 – ISO 13485Technology Transfer
Identification and quantification of endocrine disruptor chemicals
Biomaterials and Medical devices
Rescoll Testing provides analysis services for evaluating the physico-chemical, chemical, physical and morphological properties of biomaterials and medical devices. RESCOLL canhelp you meet your needs for product stability, packaging and cleaning validation. All work is performed inISO 17025 and ISO 9001 laboratories.
Impossible d’afficher l’image.
BIOMATERIAL DEVELOPMENT PRODUCT DEVELOPMENT EQUIPEMENT
Rescoll development, with 15 years of experience, Rescoll hasbecome a leader in innovative biomaterial and medical device development. With a team of over 50doctors, engineers and technicians, RESCOLL is involved in medical device development for orthopedic,ophthalmic, cardiovascular, dental, gastrointestinal, and dermal applications.
Biomaterials and Medical devicesImpossible d’afficher l’image.
H&M : Development of metallic biomaterials bearing surfaces functionalized withantibiotics and able to release active molecules only when infection occurs. Themechanism of action is based on the fixation of antibiotics via covalent bonds whichare cleaved during infection due to the decrease of pH.Project will be supported by FUI 17
RIBIO : Development of homogenous and adhesive surface coating using polymer ontitanium in order to enhance healing and antiseptic properties.Project supported by FUI 11, F1106038V
HOBBIT: Innovative composite material (organic /bioactive ceramic) with gradientsof mechanical properties and resorption to develop resorbable implants.Project supported by FUI 8, 092906353
ARDENT : Synthesis and characterization of pharmaceutical microspheres for dentaltissue regeneration using new biocompatible materials, their completemicrostructural characterization, and the study of their degradability and release ofactive substances.Project supported by Institut Carnot I@L
CHITOART : The objective of this project is to develop a tissue-engineered vascularconduit that remains in-situ physiologically functional over the long term, containingthe core elements of a vascular tissue.Project will be supported by ANR (TecSAN)
TEH-TUBE : Tissue Engineering of the right Heart outflow tract by a biofunctionalized bioresorbable polymeric valved TUBE. Project co-funded under FP7 : 604049
SPIDIMAN : Development of a new surface treatment and glucose sensitivefluorescent coating technology applied onto a standard insulin catheter andincorporated into a single port artificial pancreas system.Project co-funded under FP7 : 305343
ANASTOMOSEAL : Development of biomaterials with adhesion properties forimplantable medical devices. Perform mechanical characterization of adhesionover inert and biological substrates. Project co-funded under FP7 : 280929
Rescoll Manufacturing can help you to solve your problems andmeet your needs in prototyping, manufacturing, finishing and controls. All stages are conducted in an ISO13485 certified environment.
Medical devices and instruments
ISO 9001ISO 13485
Our ambition is to offer a wide range of tools to help you develop your innovative projects and reach yourmarket as quickly and safely as possible.
ISO 9001ISO 13485
Rescoll approvals and certifications:
Our design & management tools:
Rescoll Manufacturing certifications:
ISO 9001 / ISO 17025 (COFRAC)CIR (Crédit d’Import Recherche)Court appointed expert by first instance and commerce court of Bordeaux
ISO 13485ISO 9001
All testing, development and manufacturing are conducted in a secure environment.
Before 2010 : Turnover 3,9 M€Company with high technology and working mainly for aerospace industry.Continuous and substantial growth with good profitability.
Today: Turnover 6 M€Strategy of diversification in the medical New chain of medical manufacturing (Extrusion) Clean room for packaging & Coating medical (ISO 7) Founding member MEDPHARMPLAST EC Experts to establish the project roadmaps for call 2017_2020 (Biomaterials)
Acquisition of a company specializing in the manufacture of MD= Rescoll Manufacturing Extend the possibilities of
processes; manufacture of innovative products (ATMP, intelligent link ....) - Additive Manufacturing for Polymer & Composite - Electrospinningto be recognized as must subcontractors for medical devices
Accreditedfor testingMD (ISO 17025)
Holzapfel BM, et al, How smart do biomaterials need to be? A translational science and clinical point of view. Adv Drug Deliv Rev. 2013 Apr;65(4):581-603. 2012
strategies:
Cells and / or biomaterials functionalized
SUPPORTE / STIMULATE/ SUPPORTER
Endogenous regeneration of functional tissue
Regenerative Medicine
Molecules
Tissue
Relevance of Rescoll development : in line with Biomaterialsevolution